TELA Bio (TELA) Gross Profit (2018 - 2026)

TELA Bio has reported Gross Profit for 9 years, with the latest figure at $13.9 million in Q2 2026.

• On a quarterly basis, Gross Profit fell 1.15% year-over-year to $13.9 million in Q2 2026; TTM through Jun 2026 was $54.2 million, a 6.89% increase from a year earlier, with the FY2025 full-year figure at $54.3 million, up 16.89% from the prior year.
• Gross Profit was $13.9 million for Q2 2026 at TELA Bio, up from $12.5 million in the prior quarter.
• The five-year high for Gross Profit was $14.1 million in Q2 2025, with the low at $5.0 million in Q1 2022.
• Average Gross Profit over 5 years is $10.8 million, with a median of $11.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit soared 59.04% in 2022, then declined 3.47% in 2024.
• Over 5 years, Gross Profit stood at $8.2 million in 2022, then surged by 42.17% to $11.6 million in 2023, then dropped by 3.47% to $11.2 million in 2024, then rose by 22.58% to $13.8 million in 2025, then increased by 1.37% to $13.9 million in 2026.
• The last three Gross Profit figures came in at $13.9 million (Q2 2026), $12.5 million (Q1 2026), and $13.8 million (Q4 2025), per Business Quant data.